|
TWI675662B
|
|
Crystal forms B, C, and D of Ribociclib succinate salts and derivative thereof, and thier preparation method and composition
|
|
TW201915009A
|
|
Method for synthesizing etelcalcetide or salts thereof
|
|
TWI599571B
|
|
Process for prepararing intermediate compound of ixazomib citrate, and ixazomib citrate made thereby
|
|
TWI616447B
|
|
Crystal form d of baricitinib phosphate and composition thereof
|
|
TWI591177B
|
|
Method of preparing glucagon-like peptide 2 (GLP-2) analog
|
|
TW201811732A
|
|
Method for preparing sacubitril sodium salt and application thereof
|
|
TW201806936A
|
|
Amorphous form of valsartan/sacubitril trisodium salt and process for the preparation thereof
|
|
TWI571460B
|
|
Process for producing diamine derivative
|
|
TW201722941A
|
|
Method for preparing amorphous carfilzomib (i)
|
|
TW201408682A
|
|
Method for preparing 42-(dimethylphosphinate) Rapamycin with high conversion rate
|
|
TW201103897A
|
|
Purification method of mycophenolic acid and method for preparing high purity sodium mycophenolate using the same
|
|
TW201035104A
|
|
Improved synthesis method for Temsirolimus and its similar compounds
|
|
TW201024322A
|
|
Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate
|
|
TW200948361A
|
|
Method for synthesizing Biolimus A9 and the like and method for improving stability of the same
|
|
TW200609229A
|
|
The polymorphic form of sodium mycophenolate and its producing method
|
